Continuation of Trastuzumab Beyond Disease Progression Is Feasible and Safe in Patients with Metastatic Breast Cancer: A Retrospective Analysis of 80 Cases by the Hellenic Cooperative Oncology Group

MLA

Fountzilas, George, et al. “Continuation of Trastuzumab Beyond Disease Progression Is Feasible and Safe in Patients with Metastatic Breast Cancer: A Retrospective Analysis of 80 Cases by the Hellenic Cooperative Oncology Group.” Clinical Breast Cancer, vol. 4, no. 2, June 2003, pp. 120–25. EBSCOhost, https://doi.org/10.3816/CBC.2003.n.017.

APA

Fountzilas, G., Razis, E., Tsavdaridis, D., Karina, M., Labropoulos, S., Christodoulou, C., Mavroudis, D., Gogas, H., Georgoulias, V., & Skarlos, D. (2003). Continuation of Trastuzumab Beyond Disease Progression Is Feasible and Safe in Patients with Metastatic Breast Cancer: A Retrospective Analysis of 80 Cases by the Hellenic Cooperative Oncology Group. Clinical Breast Cancer, 4(2), 120–125. https://doi.org/10.3816/CBC.2003.n.017

Chicago

Fountzilas, George, Evangelia Razis, Dimitrios Tsavdaridis, Maria Karina, Stefanos Labropoulos, Christos Christodoulou, Dimitrios Mavroudis, Helen Gogas, Vassilios Georgoulias, and Dimosthenis Skarlos. 2003. “Continuation of Trastuzumab Beyond Disease Progression Is Feasible and Safe in Patients with Metastatic Breast Cancer: A Retrospective Analysis of 80 Cases by the Hellenic Cooperative Oncology Group.” Clinical Breast Cancer 4 (2): 120–25. doi:10.3816/CBC.2003.n.017.